Actively Recruiting
Study to Assess the Safety and Effectiveness of BAFFR CAR-T Therapy in Adults with Relapsed or Resistant B-cell Cancers
Led by Donghua Zhang · Updated on 2026-01-16
28
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating BAFFR CAR-T therapy for people with relapsed or refractory B-cell malignancies, cancers that have returned or do not respond to treatment. This prospective, single-arm, multi-center clinical study aims to assess the safety and effectiveness of this therapy. The trial plans to enroll 30 participants aged 18 to 85 years who have previously undergone treatments including anti-CD20 agents and anthracycline-containing regimens, with confirmed BAFFR target expression on their tumors. Participants will receive an infusion of the BAFFR CAR-T therapy designed specifically for their condition. The study involves monitoring safety and treatment outcomes after the infusion, with no placebo or comparison groups. The treatment requires accessible venous access for apheresis, and participants must have recovered from previous treatment toxicities. The study will track participants over time to evaluate overall survival at multiple points from 1 month up to 24 months after treatment. During the study, participants will undergo follow-up examinations and treatment procedures as scheduled. Researchers will measure overall survival rates to understand the therapys impact. Patients are required to have adequate organ function and performance status to safely participate. Safety monitoring includes assessing organ function, infections, and allergic reactions. The total duration of involvement includes treatment and long-term follow-up until at least two years after the infusion to observe outcomes and potential side effects.
CONDITIONS
Brief Title
Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here